Wesana Health Announces Closing of Previously Announced SANA-013 Asset Sale
July 05, 2023 07:30 ET
|
Wesana Health
CHICAGO and TORONTO, July 05, 2023 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE:WESA; OTCQB:WSNAF), today announced the successful closing of the sale by Wesana...
Wesana Health Announces Voting Results of AGSM
June 09, 2023 16:48 ET
|
Wesana Health
CHICAGO and TORONTO, June 09, 2023 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF), today announced that all matters put forward at the...
Wesana Health Announces Sale of SANA-13 Assets to Lucy Scientific Discovery
March 21, 2023 09:00 ET
|
Wesana Health
CHICAGO and TORONTO, March 21, 2023 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF), a data-driven life sciences company, today announced that...
Wesana Health Announces Receipt of Short-Term Loan
December 16, 2022 17:00 ET
|
Wesana Health
CHICAGO and TORONTO, Dec. 16, 2022 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF), a data-driven life sciences company, today announced that...
Wesana Announces Sale of Clinic Management Services Organization
September 01, 2022 19:15 ET
|
Wesana Health
CHICAGO and TORONTO, Sept. 01, 2022 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF), a data-driven life sciences company focused on developing...
Wesana Announces Second Quarter 2022 Financial Results
August 29, 2022 20:00 ET
|
Wesana Health
CHICAGO and TORONTO, Aug. 29, 2022 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF), a data-driven life sciences company focused on developing...
Wesana Health CEO Daniel Carcillo to Keynote Charles River Symposium: Re-Imagining Substance Abuse, Addiction, and Mental Health Disorders with Psychedelic Therapies
June 08, 2022 09:46 ET
|
Wesana Health
CHICAGO and TORONTO, June 08, 2022 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF), a data-driven life sciences company focused on developing...
Wesana Announces First Quarter 2022 Financial Results
May 31, 2022 17:30 ET
|
Wesana Health
CHICAGO and TORONTO, May 31, 2022 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF), a data-driven life sciences company focused on developing the...
Wesana Health Outlines Accelerated Drug Development Pathway
May 10, 2022 07:30 ET
|
Wesana Health
CHICAGO and TORONTO, May 10, 2022 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF), a data-driven life sciences company focused on developing the...
Wesana Announces Singular Focus on Drug Development Prompting a Strategic Review of its Clinics and Other Care Delivery Assets
May 05, 2022 09:09 ET
|
Wesana Health
CHICAGO and TORONTO, May 05, 2022 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF), a data-driven life sciences company focused on developing the...